Real-time PCR as a versatile tool for investigating the susceptibility of human herpesvirus 6 to antiviral agents

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 9, 2003, Pages 3021-3024

  Macé, Muriel ^a   Manichanh, Chaysavanh ^a,c   Bonnafous, Pascale ^a   Précigout, Stéphanie ^a   Boutolleau, David ^a   Gautheret Dejean, Agnès ^a,b   Agut, Henri ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^c CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CIDOFOVIR; FOSCARNET; GANCICLOVIR;

ANTIBIOTIC SENSITIVITY; ARTICLE; HUMAN HERPESVIRUS 6; KINETICS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; VIROGENESIS; VIRUS MUTANT; VIRUS MUTATION; VIRUS STRAIN;

ANTIVIRAL AGENTS; CELLS, CULTURED; DNA, VIRAL; FLOW CYTOMETRY; HERPESVIRUS 6, HUMAN; HUMANS; MICROBIAL SENSITIVITY TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

EID: 0042924290     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.9.3021-3024.2003     Document Type: Article

References (15)

1. Ablashi, D. V., H. B. Eastman, C. B. Owen, M. M. Roman, J. Friedman, J. B. Zabriskie, D. L. Peterson, G. R. Pearson, and J. E. Whitman. 2000. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J. Clin. Virol. 16:179-191.
2. Agut, H., H. Collandre, J. T. Aubin, D. Guetard, V. Favier, D. Ingrand, L. Montagnier, and J. M. Huraux. 1989. In vitro sensitivity of human herpes-virus-6 to antiviral drugs. Res. Virol. 140:219-228.
3. Akesson-Johansson, A., J. Harmenberg, B. Wahren, and A. Linde. 1990. Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds. Antimicrob. Agents Chemother. 34:2417-2419.
4. Boutolleau, D., C. Fernandez, E. Andre, B. M. Imbert-Marcille, N. Milpied, H. Agut, and A. Gautheret-Dejean. 2003. Human herpesvirus (HHV)-6 and HHV-7: two closely related viruses with different infection profiles in stem cell transplantation recipients. J. Infect. Dis. 187:179-186.
5. Challoner, P. B., K. T. Smith, J. D. Parker, D. L. MacLeod, S. N. Coulter, T. M. Rose, E. R. Schultz, J. L. Bennett, R. L. Garber, M. Chang, et al. 1995. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl. Acad. Sci. USA 92:7440-7444.
6. Drobyski, W. R., K. K. Knox, D. Majewski, and D. R. Carrigan. 1994. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N. Engl. J. Med. 330:1356-1360.
7. Gautheret-Dejean, A., C. Manichanh, F. Thien-Ah-Koon, A. M. Fillet, N. Mangeney, M. Vidaud, N. Dhedin, J. P. Vernant, and H. Agut. 2002. Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients. J. Virol. Methods 100:27-35.
8. Manichanh, C., P. Grenot, A. Gautheret-Dejean, P. Debre, J. M. Huraux, and H. Agut. 2000. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis. Cytometry 40:135-140.
9. Manichanh, C., C. Olivier-Aubron, J. P. Lagarde, J. T. Aubin, P. Bossi, A. Gautheret-Dejean, J. M. Huraux, and H. Agut. 2001. Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo. J. Gen. Virol. 82: 2767-2776.
10. Ratnamohan, V. M., J. Chapman, H. Howse, K. Bovington, P. Robertson, K. Byth, R. Allen, and A. L. Cunningham. 1998. Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation. Transplantation 66:877-882.
11. Reymen, D., L. Naesens, J. Balzarini, A. Holy, H. Dvorakova, and E. De Clercq. 1995. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral Res. 28:343-357.
12. Robert, C., V. Massonneau, P. Pothier, A. Clement, G. Hejblum, P. Hubert, J. T. Aubin, and H. Agut. 1998. Selection and characterization of two specific monoclonal antibodies directed against the two variants of human herpes-virus-6. Res. Virol. 149:403-411.
13. Stranska, R., A. M. Van Loon, M. Polman, and R. Schuurman. 2002. Application of real-time PCR for determination of antiviral drug susceptibility of herpes simplex virus. Antimicrob. Agents Chemother. 46:2943-2947.
14. Wang, P., K. Abe, T. Ojima, J. H. Ohyashiki, H. Satoh, T. Maruyama, H. Nagata, H. Tanaka, and K. Yamamoto. 2001. 3′-Fluorine-substitution in 3′-fluorocarbocylic oxetanocin A augments the drug's inhibition of HHV-6 B propagation in chronically infected cultures. Microbiol. Immunol. 45:457-466.
15. Yamanishi, K., T. Okuno, K. Shiraki, M. Takahashi, T. Kondo, Y. Asano, and T. Kurata. 1988. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet i:1065-1067.